Endolymphatic Duct Blockage Beneficial for Vertigo in Meniere Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on July 3, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 3, 2024 -- Endolymphatic duct blockage (EDB) is more effective than intratympanic methylprednisolone (ITMP) injection for controlling vertigo symptoms among patients with Meniere disease (MD), according to a study published online May 24 in the European Archives of Oto-Rhino-Laryngology.

Issam Saliba, M.D., from the University of Montreal Hospital Research Centre, and colleagues conducted a retrospective study to compare the effectiveness of EDB and ITMP injection to control refractory MD symptoms. Overall, 36 patients received ITMP injection and 52 underwent EDB.

The researchers found that at 24 months postoperatively, 90.4 and 43.4 percent of the EDB and ITMP groups, respectively, had complete control of vertigo. No significant difference was seen in tinnitus or aural fullness control. The reduction in tinnitus and aural fullness frequency at 24 months was significant within the EDB group; for the ITMP group, only the reduction in tinnitus was significant. Compared with preoperative levels, at 24 months, pure-tone average, bone conduction average, and speech discrimination score were significantly worse in the ITMP group. In the EDB group, pure-tone average was stable, with no difference relative to the ITMP group; bone conduction average and speech discrimination score were stable and better, respectively, than that seen in the ITMP group. No significant difference was seen in vestibular paresis before and after treatment in each group.

"Endolymphatic duct blockage surgery for the treatment of refractory Meniere's disease is an effective procedure that results in excellent vertigo control, significant improvement of aural fullness and tinnitus, and preserved hearing function at the postoperative period of 24 months," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-04 03:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords